ConvaTec allocates tightly-priced deal
ConvaTec allocated a series of amendments to its outstanding debt on Tuesday. The UK developer of medical technologies was able to price the term loan ‘B’ at the tight end of guidance and also chose to modify its structure to feature dollars more heavily.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast